Endotyping Insulin–Glucose Homeostasis in Hidradenitis Suppurativa: The Impact of Diabetes Mellitus and Inflammation
Open Access
- 21 March 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2145
Abstract
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease often associated with metabolic disorders such as diabetes mellitus. Recent research suggests a link between systemic inflammation and insulin–glucose dysregulation in HS. This study investigates the relationship between insulin–glucose homeostasis, diabetes mellitus and the haptoglobin concentration in HS patients. Methods: We assessed 95 HS patients and 49 controls using validated fasting-based function tests, including the Structural Parameter Inference Approach (SPINA), Homeostasis Model Assessment (HOMA) and Quantitative Insulin Sensitivity Check Index (QUICKI). Results: The HS patients had a significantly higher fasting insulin concentration (97.2 vs. 69.0 pmol/L, p = 0.035), increased insulin resistance (HOMA-IR: 3.47 vs. 2.57, p = 0.016) and impaired insulin sensitivity (SPINA-GR: 1.34 vs. 1.76 mol/s, p = 0.017). In diabetes, the insulin sensitivity was more strongly reduced (SPINA-GR: 0.61 vs. 1.41 mol/s, p = 0.0057) and the insulin resistance increased (HOMA-IR: 7.3 vs. 3.2, p = 0.017). Higher haptoglobin concentrations were accompanied by worse glycaemic control, demonstrating a significantly elevated fasting glucose (5.77 vs. 5.11 mmol/L, p = 0.043) concentration and HbA1c (5.7% vs. 5.4%, p = 0.0081) fraction. Conclusions: Our findings suggest that chronic inflammation in HS contributes to metabolic dysregulation, worsening insulin resistance and glycaemic control, particularly in those with elevated haptoglobin or diabetes.Keywords
This publication has 53 references indexed in Scilit:
- Systematic review and meta‐analysis of peripheral blood inflammatory markers in hidradenitis SuppurativaThe Journal of Dermatology, 2025
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes MellitusCutis, 2025
- Advances in Microbiome‐Based Therapeutics for Dermatological Disorders: Current Insights and Future DirectionsExperimental Dermatology, 2024
- Hidradenitis suppurativa and its association with obesity, smoking, and diabetes mellitus: A systematic review and meta‐analysisInternational Wound Journal, 2024
- Screening for cardiometabolic risk factors in patients with psoriasis and hidradenitis suppurativa: A pilot study in a safety net populationJournal of the American Academy of Dermatology, 2024
- Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative ReviewSkin Appendage Disorders, 2024
- Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and RosaceaActa Dermato-Venereologica, 2023
- Hidradenitis suppurativa is an autoinflammatory keratinization disease: A review of the clinical, histologic, and molecular evidenceJAAD International, 2020
- An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes MellitusJournal of Diabetes Research, 2016
- Inflammation, stress, and diabetesJournal of Clinical Investigation, 2005